Eikon Therapeutics
Miki Hardy is currently the Director of Lab Operations at Eikon Therapeutics since February 2020. Prior to this role, Miki worked as a Senior Associate Scientist at Amgen from January 1998 to December 2019.
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.